β1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 35, 2010, Pages 15559-15564

  Huck, L ^a   Pontier, S M ^a,b   Zuo, D M ^a   Muller, W J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUT PASTEUR   (France)

Author keywords

Metastasis; Tumorigenesis

Indexed keywords

BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; CD31 ANTIGEN; KI 67 ANTIGEN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; CELL PROLIFERATION; DISEASE COURSE; EXPERIMENTAL NEOPLASM; GENE DELETION; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALIA; MUS; POLYOMAVIRUS;

ANIMALS; ANTIGENS, CD29; ANTIGENS, CD31; APOPTOSIS; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE DELETION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, ERBB-2;

EID: 77957283664     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1003034107     Document Type: Article

References (27)

1. Grasso AW, et al. (1997) ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene 15:2705-2716.
2. Guo W, et al. (2006) Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126:489-502.
3. Kren A, et al. (2007) Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J 26:2832-2842.
4. White DE, et al. (2004) Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6:159-170.
5. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ (2008) Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res 68:4398-4405.
6. Lahlou H, et al. (2007) Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci USA 104:20302-20307.
7. McLean GW, et al. (2004) Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev 18:2998-3003.
8. Provenzano PP, Inman DR, Eliceiri KW, Beggs HE, Keely PJ (2008) Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol 173:1551-1565.
9. Pylayeva Y, et al. (2009) Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119:252-266.
10. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ (1994) Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 8:23-32.
11. Pontier SM, et al. (2010) Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene 29:3374-3385.
12. Ranger JJ, Levy DE, Shahalizadeh S, Hallett M, Muller WJ (2009) Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. Cancer Res 69:6823-6830.
13. Ursini-Siegel J, et al. (2008) ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J 27:910-920. (Pubitemid 351417168)
14. Bloch W, et al. (1997) Beta 1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol 139:265-278.
15. Senger DR, et al. (2002) The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 160:195-204.
16. Caswell PT, et al. (2008) Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J Cell Biol 183:143-155.
17. Ferreira M, Fujiwara H, Morita K, Watt FM (2009) An activating beta1 integrin mutation increases the conversion of benign to malignant skin tumors. Cancer Res 69:1334-1342.
18. Weaver VM, et al. (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231-245.
19. Muller PA, et al. (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell 139:1327-1341.
20. Park CC, et al. (2006) Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 66:1526-1535.
21. Nam JM, Onodera Y, Bissell MJ, Park CC (2010) Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res 70:5238-5248.
22. Zhang X, et al. (2009) Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo. Mol Cancer Ther 8:499-508.
23. Weigelt B, Lo AT, Park CC, Gray JW, Bissell MJ (2010) HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Treat 122:35-43.
24. Mills GB, Jurisica I, Yarden Y, Norma JC (2009) Genomic amplicons target vesicle recycling in breast cancer. J Clin Invest, 10.1172/JCI40256.
25. Zhang F, et al. (2009) PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol 19:524-529.
26. Troussard AA, et al. (2003) Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278:22374-22378.
27. Terpstra L, et al. (2003) Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol 162:139-148.